gBETA Medtech
Overview
gBETA Medtech is a free, seven-week, pre-accelerator program for early-stage companies in the medical device, healthcare software, biotech, and diagnostics sectors. It is a program run by the nationally ranked accelerator gener8tor. The program provides individualized coaching, mentorship, and access to a network of investors and industry experts to help startups gain traction and prepare for seed investment or equity-based accelerators. The program does not take equity or charge fees.
Portfolio Companies
7
Website
gener8tor.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kobara Medical, Inc. | May 2018 | Accelerator | Co-investor |
| Delve Health | Nov 2021 | Accelerator | Co-investor |
| bTECH | Nov 2021 | Grant | Co-investor |
| TruDiary | Dec 2021 | Accelerator | Lead |
| Anatomic | Feb 2020 | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is gBETA Medtech based?
gBETA Medtech is headquartered in Madison, Wisconsin, United States.
When was gBETA Medtech founded?
Founding year information for gBETA Medtech is not publicly available.
How many portfolio companies does gBETA Medtech have?
gBETA Medtech has 7 portfolio companies in Caplight's dataset.
What are some companies in gBETA Medtech's portfolio?
Portfolio companies visible on Caplight include Kobara Medical, Inc., Delve Health, bTECH, TruDiary, Anatomic.
What was gBETA Medtech's most recent investment shown here?
gBETA Medtech's most recent investment in this portfolio sample was in TruDiary in 2021.
What sectors does gBETA Medtech focus on?
gBETA Medtech focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce, Enterprise Software.
What company stages does gBETA Medtech focus on?
gBETA Medtech typically invests at the Early stage.